Literature DB >> 9013302

Treatment of polycystic ovary patients undergoing IVF.

P N Barri1, B Coroleu, F Martinez, J M Traver, A Veiga, G Calderon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9013302      PMCID： PMC3454708          DOI： 10.1007/bf02765743

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  15 in total

Review 1.  Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.

Authors:  A H Balen; S L Tan; H S Jacobs
Journal:  Br J Obstet Gynaecol       Date:  1993-12

Review 2.  Assisted reproduction techniques in polycystic ovarian syndrome.

Authors:  B C Tarlatzis; G Grimbizis
Journal:  Ann N Y Acad Sci       Date:  1993-05-28       Impact factor: 5.691

Review 3.  Endocrine monitoring for assisted human conception.

Authors:  C M Howles; M C Macnamee
Journal:  Br Med Bull       Date:  1990-07       Impact factor: 4.291

4.  Consequences of high ovarian response to gonadotropins: a cytogenetic analysis of unfertilized human oocytes.

Authors:  J J Tarín; A Pellicer
Journal:  Fertil Steril       Date:  1990-10       Impact factor: 7.329

5.  Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization.

Authors:  J Remohi; A Vidal; A Pellicer
Journal:  Fertil Steril       Date:  1993-06       Impact factor: 7.329

Review 6.  Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization.

Authors:  R P Buyalos; C T Lee
Journal:  Fertil Steril       Date:  1996-01       Impact factor: 7.329

7.  Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients.

Authors:  C Simón; F Cano; D Valbuena; J Remohí; A Pellicer
Journal:  Hum Reprod       Date:  1995-09       Impact factor: 6.918

8.  The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.

Authors:  B C Tarlatzis; G Grimbizis; F Pournaropoulos; J Bontis; S Lagos; E Spanos; S Mantalenakis
Journal:  Hum Reprod       Date:  1995-10       Impact factor: 6.918

9.  Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.

Authors:  R Homburg; T Levy; Z Ben-Rafael
Journal:  Hum Reprod       Date:  1995-10       Impact factor: 6.918

10.  Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study.

Authors:  Z Shoham; A Weissman; A Barash; R Borenstein; M Schachter; V Insler
Journal:  Fertil Steril       Date:  1994-07       Impact factor: 7.329
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.